A booster study of MVA-BN-RSV Vaccine.
Phase of Trial: Phase II
Latest Information Update: 09 Nov 2017
At a glance
- Drugs MVA-BN RSV (Primary)
- Indications Respiratory syncytial virus infections
- Focus Therapeutic Use
- 09 Nov 2017 According to a Bavarian Nordic media release, dosing has been commenced in the trial.
- 09 Nov 2017 Status changed from planning to recruiting, according to a Bavarian Nordic media release.
- 08 Nov 2017 According to a Bavarian Nordic media release, this trial is expected to initiate in the second half of 2017.